World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
45360
World Ranking
5981
National Ranking
227

Overview

Pieter E. Postmus is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on medicine, with a significant number of publications in pulmonary and respiratory medicine as well as oncology and related biomedical fields.

Their published works span several key areas including lung cancer treatments and mutations, lung cancer diagnosis and treatment, cancer genomics and diagnostics, renal cell carcinoma treatment, effects of radiation exposure, RNA modifications and cancer, and cancer immunotherapy and biomarkers.

Recent papers by Pieter E. Postmus include the following:

  • The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer, 2020, Journal of Thoracic Oncology
  • Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing, 2020, Journal of Thoracic Oncology
  • Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach, 2021, EClinicalMedicine
  • Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer, 2021, Histopathology
  • The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study, 2020, Cancer Treatment and Research Communications

Pieter E. Postmus frequently collaborates with a number of coauthors, including:

  • Daniëlle Cohen
  • Jan H. von der Thüsen
  • Liesbeth M. Hondelink
  • S.R.S. Ramai
  • Bart P.C. Hoppe

Their research is often published in several prominent venues, notably:

  • Journal of Thoracic Oncology
  • Histopathology
  • American Journal of Respiratory and Critical Care Medicine
  • EClinicalMedicine
  • Cancer Treatment and Research Communications

Best Publications

  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

    Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim

  • The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Ramón Rami-Porta;David Ball;John Crowley;Dorothy J. Giroux

  • Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

    Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan

  • Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

    Berend J Slotman;Corinne Faivre-Finn;Gijs Kramer;Elaine M Rankin

  • Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

    Harm Van Tinteren;Otto S. Hoekstra;Egbert F. Smit;Jan H.A.M. Van Den Bergh

  • Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

    Serge A van Wolferen;Johannes T Marcus;Anco Boonstra;Koen M J Marques

  • The international association for the study of lung cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer

    Frances A. Shepherd;John J. Crowley;Paul Van Houtte;Pieter E. Postmus

  • Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

    Andrea Ardizzoni;Heine Hansen;Per Dombernowsky;Teresa Gamucci

  • The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

    Eric Vallières;Frances A. Shepherd;John J. Crowley;Paul Van Houtte

  • Prognostic factors in patients with pleural mesothelioma : The European Organization for Research and Treatment of Cancer Experience

    D Curran;T Sahmoud;P Therasse;J van Meerbeeck

  • Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

    Frederick Arce Vargas;Andrew J S Furness;Kevin Litchfield;Kroopa Joshi

  • Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

    Klaas Kok;Jan Osinga;Ben Carritt;Mary B. Davis

  • Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.

    Frederick Arce Vargas;Andrew J.S. Furness;Andrew J.S. Furness;Isabelle Solomon;Kroopa Joshi;Kroopa Joshi

  • Current aspects of spontaneous pneumothorax

    F. M. N. H. Schramel;P. E. Postmus;R. G. J. R. A. Vanderschueren

  • Noninvasively Assessed Pulmonary Artery Stiffness Predicts Mortality in Pulmonary Arterial Hypertension

    C. Tji-Joong Gan;Jan-Willem Lankhaar;Nico Westerhof;J. Tim Marcus

  • Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer

    Ramaswamy Govindan;Aleksandra Szczesna;Myung Ju Ahn;Claus Peter Schneider

  • Right ventricular diastolic impairment in patients with pulmonary arterial hypertension

    Silvia Rain;M Louis Handoko;Pia Trip;C Tji-Joong Gan

  • Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension.

    C Tji-Joong Gan;Jan-Willem Lankhaar;J Tim Marcus;Nico Westerhof

  • Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

    Astrid A.M. Van der Veldt;Mark Lubberink;Mark Lubberink;Idris Bahce;Maudy Walraven

Frequent Co-Authors

Egbert F. Smit
Egbert F. Smit VU University Medical Center
Anton Vonk-Noordegraaf
Anton Vonk-Noordegraaf Amsterdam University Medical Centers
Nico Westerhof
Nico Westerhof VU University Medical Center
Peter J.F. Snijders
Peter J.F. Snijders Vrije Universiteit Amsterdam
Suresh Senan
Suresh Senan University of Amsterdam
Fred H. Menko
Fred H. Menko Netherlands Cancer Institute
Otto S. Hoekstra
Otto S. Hoekstra Amsterdam UMC
Andrea Ardizzoni
Andrea Ardizzoni University of Bologna
Martin Reck
Martin Reck LungenClinic Grosshansdorf
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a range of related careers and flexible online degrees. Many students consider alternative healthcare roles or bridging programs that align with their career goals and personal circumstances. For those interested in nursing, there are direct entry msn programs online—these are designed for non-nurses seeking a fast-track to an advanced nursing degree without starting from scratch.

If you’re concerned about tough admission standards, you might explore easiest nursing programs to get into. These schools typically have more flexible requirements, giving more students a chance to start their nursing career.

Those attracted to administrative healthcare roles may want to learn about financial aid for medical billing and coding. This can make programs in billing and coding accessible, even if you’re concerned about tuition costs.

Finally, for prospective nurses who want to avoid lengthy entry exams, there are options such as an lpn program without teas test. These programs make entering healthcare more attainable for those anxious about standardized test requirements.

Best Scientists Citing Pieter E. Postmus

Trending Scientists

Recently Published Articles